Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 30.77%321.19M | 15.68%348.76M | -9.35%460.35M | 135.59%349.88M | -3.91%245.61M | -15.72%301.48M | -24.84%507.85M | 74.48%148.51M | 18.42%255.59M | 100.65%357.71M |
| Notes receivable and accounts receivable | -6.10%761.42M | 56.33%988.31M | 102.64%1.22B | 54.08%1.02B | 23.50%810.92M | 7.13%632.2M | 22.53%601.08M | 56.89%659.43M | 60.13%656.61M | 73.93%590.15M |
| -Notes receivable | 196.03%20.29M | 313.05%7.5M | 66.54%9.72M | 132.14%8M | 146.64%6.85M | -14.89%1.82M | 35.21%5.84M | -1.02%3.45M | 1,189.94%2.78M | --2.13M |
| -Accounts receivable | -7.83%741.13M | 55.59%980.81M | 102.99%1.21B | 53.67%1.01B | 22.98%804.06M | 7.21%630.39M | 22.42%595.24M | 57.38%655.98M | 59.53%653.83M | 73.30%588.01M |
| Other receivables (including interest and dividends) | 20.25%11.64M | 3.96%8.58M | -12.86%8.85M | -22.22%6.99M | -29.51%9.68M | -29.59%8.26M | -36.16%10.16M | -40.89%8.99M | -42.04%13.73M | -42.51%11.72M |
| -Dividend receivable | ---- | ---- | ---- | ---- | --1.05M | ---- | ---- | ---- | ---- | ---- |
| -Other receivable | ---- | 3.96%8.58M | ---- | ---- | ---- | -29.59%8.26M | ---- | -40.89%8.99M | ---- | -42.51%11.72M |
| Advance payment | 203.20%65.5M | 11.26%40.37M | 105.36%28.87M | 11.42%17.73M | -25.37%21.6M | -37.94%36.28M | -77.22%14.06M | -69.62%15.91M | 184.52%28.94M | 542.79%58.47M |
| Inventories | 72.46%812.16M | 39.66%802.12M | 8.20%702.84M | 23.60%650.55M | -3.53%470.93M | 26.14%574.36M | 21.67%649.54M | 7.33%526.32M | -3.59%488.14M | -5.34%455.33M |
| Receivable financing | 51.72%26.74M | -80.09%9.7M | -92.40%4.03M | -74.00%9.99M | 23.90%17.62M | 251.13%48.69M | 186.87%53.09M | 650.20%38.43M | 329.68%14.22M | -36.13%13.87M |
| Non-current assets due within one year | --2.06M | --3.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | 29.20%374.83M | 28.12%334.19M | -10.19%203.81M | 10.45%229.4M | 53.94%290.12M | 72.56%260.84M | 38.89%226.94M | 3.57%207.7M | -16.62%188.46M | -15.89%151.16M |
| Total current assets | 27.27%2.38B | 36.15%2.54B | 27.34%2.63B | 42.07%2.28B | 13.42%1.87B | 13.65%1.86B | 5.26%2.06B | 26.49%1.61B | 17.94%1.65B | 33.26%1.64B |
| Non Current assets | ||||||||||
| Other non-current financial assets | -6.43%176.14M | -24.81%176.14M | -24.30%177.32M | -18.90%189.97M | -15.16%188.25M | 5.58%234.25M | 14.90%234.25M | 17.79%234.25M | 18.68%221.87M | 37.00%221.87M |
| Long-term equity investment | 10.79%56.84M | 5.45%58.23M | 1.87%59.07M | -20.64%47.66M | -14.57%51.31M | -11.38%55.23M | -8.90%57.98M | -9.09%60.06M | -4.00%60.06M | -4.15%62.32M |
| Long term receivable account | --1.59M | --1.59M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Fixed assets | ---- | -14.22%16.72M | ---- | ---- | ---- | -15.25%19.49M | ---- | -13.07%21.27M | ---- | -2.61%22.99M |
| Intangible assets | -8.61%104.73M | -9.76%102.95M | -11.17%101.05M | -8.08%109.08M | 2.78%114.6M | 9.72%114.08M | 6.08%113.76M | 57.29%118.67M | 104.28%111.49M | 136.13%103.98M |
| Development expenditure | 89.42%9.32M | 70.66%9.85M | -26.33%9.9M | -40.37%7.7M | -52.84%4.92M | -69.13%5.77M | -19.04%13.44M | 139.92%12.92M | 89.39%10.43M | 70.44%18.69M |
| Long deferred expense | 38.24%9.58M | 36.87%10.44M | -9.19%5.4M | 11.34%6.22M | 63.36%6.93M | 98.47%7.63M | 33.30%5.94M | 24.29%5.59M | 373.63%4.24M | 315.20%3.84M |
| Deferred tax assets | 29.15%89.7M | 41.97%85.13M | 35.84%85.73M | 48.43%88.41M | 8.55%69.46M | 22.27%59.96M | 50.96%63.12M | 43.28%59.56M | 24.87%63.99M | 26.14%49.04M |
| Usufruct assets | -42.10%6.98M | -65.27%5.23M | -66.11%6.76M | -60.87%9.4M | -59.10%12.05M | -55.34%15.07M | -45.72%19.95M | -41.23%24.04M | -29.37%29.46M | 19.18%33.74M |
| Other non current assets | 110.25%3.61M | -15.43%3.25M | 4.98%3.25M | -7.08%2.87M | --1.72M | --3.85M | --3.1M | 587.31%3.09M | ---- | ---- |
| Total non current assets | 1.58%475.14M | -8.88%469.53M | -12.62%464.83M | -11.21%478.94M | -10.64%467.74M | -0.22%515.32M | 6.70%531.94M | 17.87%539.44M | 22.01%523.42M | 38.17%516.48M |
| Total assets | 22.12%2.85B | 26.39%3B | 19.15%3.09B | 28.67%2.76B | 7.61%2.33B | 10.33%2.38B | 5.55%2.59B | 24.21%2.14B | 18.89%2.17B | 34.40%2.15B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 167.79%348.18M | 115.11%503.12M | 42.14%538.03M | 6,929.12%352.61M | 136.33%130.02M | 112.31%233.89M | 34.87%378.52M | -98.08%5.02M | -82.98%55.02M | -46.07%110.17M |
| Notes payable and accounts payable | 31.08%571.11M | 42.53%633.49M | 19.69%678.62M | 19.35%579.92M | 3.24%435.69M | 24.73%444.46M | 40.71%566.96M | 46.62%485.88M | 3.08%422.02M | -1.90%356.33M |
| -Notes payable | --17.62M | ---- | ---- | ---- | ---- | -60.85%12.04M | 2.01%45.09M | -13.21%36.63M | -51.40%28.18M | 10.44%30.75M |
| -Accounts payable | 27.04%553.48M | 46.50%633.49M | 30.03%678.62M | 29.09%579.92M | 10.63%435.69M | 32.82%432.42M | 45.47%521.88M | 55.35%449.25M | 12.07%393.84M | -2.93%325.58M |
| Contract liabilities | 35.30%125.09M | 37.98%121.66M | 49.94%107.39M | 108.96%109.34M | 57.48%92.45M | 67.28%88.17M | 18.16%71.62M | -22.42%52.33M | -27.18%58.7M | -29.04%52.71M |
| Salaries payable | 7.58%16.23M | 3.41%15.82M | -1.28%15.71M | -3.16%16.19M | -2.80%15.09M | -2.57%15.3M | -3.59%15.92M | -3.70%16.72M | 5.12%15.52M | 1.64%15.7M |
| Taxs payable | -46.11%13.3M | 3.32%10.96M | 84.60%18.77M | 42.58%16.09M | 62.51%24.68M | -43.70%10.61M | 10.01%10.17M | 54.12%11.29M | -0.02%15.19M | 19.99%18.84M |
| Other payable (including interest and dividends) | -2.87%44.89M | 20.96%54.69M | 418.77%59.77M | 560.30%62.17M | 103.79%46.22M | 111.90%45.22M | -43.48%11.52M | -53.93%9.42M | 5.47%22.68M | -44.55%21.34M |
| -Other payable | ---- | 20.96%54.69M | ---- | ---- | ---- | 111.90%45.22M | ---- | -53.93%9.42M | ---- | -44.55%21.34M |
| Non current liabilities due within one year | -36.82%6.29M | -53.00%5.98M | -59.56%6.31M | -47.84%8.59M | -44.66%9.95M | -30.44%12.71M | -76.80%15.59M | -75.39%16.47M | 33.28%17.98M | 70.88%18.28M |
| Other current liabilities | -37.70%18.22M | -55.18%13.57M | -2.87%25.89M | -15.87%22.99M | -2.61%29.25M | -20.02%30.28M | -9.89%26.66M | 5.24%27.33M | 7.02%30.04M | 39.57%37.86M |
| Total current liabilities | 45.95%1.14B | 54.35%1.36B | 32.23%1.45B | 87.03%1.17B | 22.95%783.35M | 39.51%880.64M | 23.65%1.1B | -21.70%624.45M | -29.72%637.15M | -15.93%631.22M |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -40.26%29.9M |
| Deferred tax liabilities | -2.82%18.28M | -33.05%18.28M | -32.00%18.57M | -29.54%19.24M | -39.58%18.81M | -14.07%27.31M | 22.91%27.31M | 30.24%27.31M | 51.98%31.14M | 55.11%31.78M |
| Long term deferred income | 0.00%3.88M | 0.00%3.88M | 0.00%3.88M | 0.00%3.88M | 0.00%3.88M | 307.89%3.88M | 307.89%3.88M | 307.89%3.88M | 83.69%3.88M | -57.72%950K |
| Lease liabilities | 44.92%3.87M | -21.70%2.56M | -92.90%428.05K | -84.76%1.42M | -80.16%2.67M | -81.26%3.27M | -72.09%6.03M | -65.66%9.3M | -56.55%13.46M | -12.13%17.43M |
| Total non current liabilities | 2.64%26.03M | -28.25%24.72M | -38.54%22.87M | -39.40%24.53M | -47.68%25.36M | -56.97%34.45M | -72.37%37.21M | -62.86%40.48M | -53.23%48.47M | -13.57%80.06M |
| Total liabilities | 44.59%1.17B | 51.24%1.38B | 29.91%1.47B | 79.33%1.19B | 17.95%808.71M | 28.65%915.09M | 10.99%1.13B | -26.64%664.93M | -32.13%685.62M | -15.67%711.27M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.32%262.63M | 0.04%261.8M | 0.04%261.8M | 0.06%261.8M | 0.12%261.8M | 0.20%261.7M | 0.21%261.69M | 9.17%261.64M | 9.12%261.5M | 9.09%261.18M |
| Capital reserve funds | 3.83%822.5M | 3.40%811.56M | 2.42%803.67M | 1.82%798.13M | 1.37%792.16M | 1.14%784.9M | 1.21%784.69M | 296.25%783.84M | 298.42%781.43M | 307.10%776.03M |
| Surplus reserve funds | 5.71%23.83M | 5.71%23.83M | 5.71%23.83M | 5.71%23.83M | 0.46%22.55M | 0.46%22.55M | 0.56%22.55M | 0.56%22.55M | 22.84%22.44M | 22.84%22.44M |
| Retained profit | 23.05%638.47M | 32.21%609.47M | 31.71%605.53M | 23.37%559.23M | 13.38%518.85M | 5.34%460.98M | 6.20%459.76M | 9.28%453.3M | 10.66%457.62M | 15.98%437.61M |
| Less:Treasury stock | -3.23%67.04M | 27.14%86.78M | 16.17%79.29M | 88.78%79.29M | 63.99%69.28M | 20.83%68.25M | 20.58%68.25M | -25.80%42M | -25.36%42.25M | -16.51%56.48M |
| Other composite income | -15.93%940.46K | -57.27%937.61K | 51.70%2.66M | 122.72%3.41M | -54.89%1.12M | -6.98%2.19M | 270.00%1.75M | 16.06%1.53M | 34.69%2.48M | 1,113.65%2.36M |
| Shareholders equity without minority interests | 10.09%1.68B | 10.71%1.62B | 10.67%1.62B | 5.82%1.57B | 2.96%1.53B | 1.45%1.46B | 1.85%1.46B | 80.72%1.48B | 82.48%1.48B | 90.34%1.44B |
| Minority interests | ---- | ---- | ---- | ---- | -720.04%-1.68M | -475.66%-1.73M | -358.84%-1.71M | -228.01%-1.07M | -80.18%270.84K | -71.34%459.3K |
| Total shareholder equity | 10.21%1.68B | 10.84%1.62B | 10.80%1.62B | 5.90%1.57B | 2.83%1.53B | 1.30%1.46B | 1.68%1.46B | 80.41%1.48B | 82.21%1.48B | 90.00%1.44B |
| Total liabilityies and equity | 22.12%2.85B | 26.39%3B | 19.15%3.09B | 28.67%2.76B | 7.61%2.33B | 10.33%2.38B | 5.55%2.59B | 24.21%2.14B | 18.89%2.17B | 34.40%2.15B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.